The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Open accessAbstract
BACKGROUND The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmission make elimination of HBV feasible. We aimed to estimate the national, regional, and global prevalence of HBsAg in the general population and in the population aged 5 years in 2016, as well as coverage of prophylaxis, diagnosis, and treatment. METHODS In this modelling study, we used a Delphi process that included a literature review in PubMed and Embase, followed by interviews with experts, to quantify the historical epidemiology of HBV infection. We then used a dynamic HBV transmission and progression model to estimate the country-level and regional-level prevalence of HBsAg in 2016 and the effect of prophylaxis and treatment on disease burden. FINDINGS We developed models for 120 countries, 78 of which were populated with data approved by experts. Using these models, we estimated that the global prevalence of HBsAg in 2016 was 3·9% (95% uncertainty interval [UI] 3·4-4·6), corresponding to 291 992 000 (251 513 000-341 114 000) infections. Of these infections, around 29 million (10%) were diagnosed, and only 4·8 million (5%) of 94 million individuals eligible for treatment actually received antiviral therapy. Around 1·8 (1·6-2·2) million infections were in children aged 5 years, with a prevalence of 1·4% (1·2-1·6). We estimated that 87% of infants had received the three-dose HBV vaccination in the first year of life, 46% had received timely birth-dose vaccination, and 13% had received hepatitis B immunoglobulin along with the full vaccination regimen. Less than 1% of mothers with a high viral load had received antiviral therapy to reduce mother-to-child transmission. INTERPRETATION Our estimate of HBV prevalence in 2016 differs from previous studies, potentially because we took into account the effect of infant prophylaxis and early childhood vaccination, as well as changing prevalence over time. Although some regions are well on their way to meeting prophylaxis and prevalence targets, all regions must substantially scale-up access to diagnosis and treatment to meet the global targets. FUNDING John C Martin Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, H., Dwyer-Lindgren, L., Lofgren, K. T., Rajaratnam, J. K., Marcus, J. R., Levin-Rector, A., Levitz, C. E., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61719-x · Cited by 810
Cited by
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.052 · Cited by 1,096
Pimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 710
Self-citationThe global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Stockdale, A. J., Kreuels, B., Henrion, M. Y. R., Giorgi, E., Kyomuhangi, I., de Martel, C., Hutin, Y., & Geretti, A. M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.008 · Cited by 688
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00760-9 · Cited by 632
Self-citationHepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Nguyen, M. H., Wong, G., Gane, E., Kao, J.-H., & Dusheiko, G. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-19 · Cited by 554
Self-citation
Metadata
- Authors
- Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., Akarca, U., Hasan, F., Al Lawati, F., Al Naamani, K., Al-Ashgar, H. I., Alavian, S. M., Alawadhi, S., Albillos, A., Al-Busafi, S. A., Aleman, S., Alfaleh, F. Z., Aljumah, A. A., Anand, A. C., Anh, N. T., Arends, J. E., Arkkila, P., Athanasakis, K., Bane, A., Ben-Ari, Z., Berg, T., Bizri, A. R., Blach, S., Brandão Mello, C. E., Brandon, S. M., Bright, B., Bruggmann, P., Brunetto, M., Buti, M., Chan, H. L. Y., Chaudhry, A., Chien, R.-N., Choi, M. S., Christensen, P. B., Chuang, W.-L., Chulanov, V., Clausen, M. R., Colombo, M., Cornberg, M., Cowie, B., Craxi, A., Croes, E. A., Cuellar, D. A., Cunningham, C., Desalegn, H., Drazilova, S., Duberg, A.-S., Egeonu, S. S., El-Sayed, M. H., Estes, C., Falconer, K., Ferraz, M. L. G., Ferreira, P. R., Flisiak, R., Frankova, S., Gaeta, G. B., García-Samaniego, J., Genov, J., Gerstoft, J., Goldis, A., Gountas, I., Gray, R., Guimarães Pessôa, M., Hajarizadeh, B., Hatzakis, A., Hézode, C., Himatt, S. M., Hoepelman, A., Hrstic, I., Hui, Y.-T. T., Husa, P., Jahis, R., Janjua, N. Z., Jarčuška, P., Jaroszewicz, J., Kaymakoglu, S., Kershenobich, D., Kondili, L. A., Konysbekova, A., Krajden, M., Kristian, P., Laleman, W., Lao, W.-C. C., Layden, J., Lazarus, J. V., Lee, M.-H., Liakina, V., Lim, Y.-S. S., Loo, C.-K. K., Lukšić, B., Malekzadeh, R., Malu, A. O., Mamatkulov, A., Manns, M., Marinho, R. T., Maticic, M., Mauss, S., Memon, M. S., Mendes Correa, M. C., Mendez-Sanchez, N., Merat, S., Metwally, A. M., Mohamed, R., Mokhbat, J. E., Moreno, C., Mossong, J., Mourad, F. H., Müllhaupt, B., Murphy, K., Musabaev, E., Nawaz, A., Nde, H. M., Negro, F., Nersesov, A., Nguyen, V. T. T., Njouom, R., Ntagirabiri, R., Nurmatov, Z., Obekpa, S., Ocama, P., Oguche, S., Omede, O., Omuemu, C., Opare-Sem, O., Opio, C. K., Örmeci, N., Papatheodoridis, G., Pasini, K., Pimenov, N., Poustchi, H., Quang, T. D., Qureshi, H., Ramji, A., Razavi-Shearer, K., Redae, B., Reesink, H. W., Rios, C. Y., Rjaskova, G., Robbins, S., Roberts, L. R., Roberts, S. K., Ryder, S. D., Safadi, R., Sagalova, O., Salupere, R., Sanai, F. M., Sanchez-Avila, J. F., Saraswat, V., Sarrazin, C., Schmelzer, J. D., Schréter, I., Scott, J., Seguin-Devaux, C., Shah, S. R., Sharara, A. I., Sharma, M., Shiha, G. E., Shin, T., Sievert, W., Sperl, J., Stärkel, P., Stedman, C., Sypsa, V., Tacke, F., Tan, S. S., Tanaka, J., Tomasiewicz, K., Urbanek, P., van der Meer, A. J., Van Vlierberghe, H., Vella, S., Vince, A., Waheed, Y., Waked, I., Walsh, N., Weis, N., Wong, V. W., Woodring, J., Yaghi, C., Yang, H.-I., Yang, C.-L., Yesmembetov, K., Yosry, A., Yuen, M.-F., Yusuf, M. A. M., Zeuzem, S., & Razavi, H.
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 3
- Issue
- 6
- Pages
- 383-403
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W2801666689
- Cited by
- 1,661
- References
- 1
- FWCI
- 126.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. https://app.cochat.ai/papers/10.1016/s2468-1253(18)30056-6
- The paper
- Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., Akarca, U., Hasan, F., Al Lawati, F., Al Naamani, K., Al-Ashgar, H. I., Alavian, S. M., Alawadhi, S., Albillos, A., Al-Busafi, S. A., . . . Razavi, H. (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(18)30056-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.